|
ZA732136B
(en)
|
1972-04-12 |
1974-03-27 |
Lilly Co Eli |
Dopamine derivatives
|
|
DE2753278A1
(de)
*
|
1977-11-30 |
1979-05-31 |
Basf Ag |
Aralkylpiperidinone
|
|
US4321386A
(en)
|
1981-01-28 |
1982-03-23 |
Mead Johnson & Company |
Quaternary piperidinium halides
|
|
DE3222152A1
(de)
*
|
1982-06-12 |
1983-12-15 |
Bayer Ag, 5090 Leverkusen |
Substituierte maleinsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
|
HU190526B
(en)
|
1983-01-31 |
1986-09-29 |
Eli Lilly And Co,Us |
Method for accelerating the growth of domestic animals for improving the utilizing of nutritive material and preventing from growing fat
|
|
JPS62283922A
(ja)
|
1986-05-30 |
1987-12-09 |
Tsumura Juntendo Inc |
血小板凝集抑制剤
|
|
US4697024A
(en)
|
1986-11-24 |
1987-09-29 |
Merrell Dow Pharmaceuticals Inc. |
Medroxalol intermediates
|
|
US4958029A
(en)
|
1987-01-13 |
1990-09-18 |
Banyu Pharmaceutical Co., Ltd. |
Process for the production of isoindoline derivatives, novel intermediates and process for their production
|
|
JPH01180822A
(ja)
|
1988-01-12 |
1989-07-18 |
Dainippon Pharmaceut Co Ltd |
抗遅延型アレルギー剤
|
|
JPH01305085A
(ja)
*
|
1988-05-31 |
1989-12-08 |
Yamanouchi Pharmaceut Co Ltd |
ピリジルチアゾリジンカルボン酸アミド誘導体
|
|
JPH02215789A
(ja)
*
|
1989-02-15 |
1990-08-28 |
Yamanouchi Pharmaceut Co Ltd |
チアゾロ［３，４―ａ］ピラジン誘導体
|
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
DE4000610A1
(de)
|
1990-01-11 |
1991-07-18 |
Knoll Ag |
Verfahren zur herstellung von optisch aktiven 3-amino-1-arylbutanen und 3-benzylamino-1-arylbutanen
|
|
JP2818958B2
(ja)
|
1990-02-23 |
1998-10-30 |
塩野義製薬株式会社 |
４―（４―アルコキシフェニル）―２―ブチルアミン誘導体およびその製造法
|
|
JPH045266A
(ja)
|
1990-04-24 |
1992-01-09 |
Toyo Pharma- Kk |
ドパミン誘導体の製造方法
|
|
DE4142366A1
(de)
|
1991-07-15 |
1993-06-24 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
PT724561E
(pt)
|
1991-08-23 |
2004-07-30 |
Nps Pharma Inc |
Arilalquil-aminas como receptores activos de calcio
|
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
|
JPH06321781A
(ja)
*
|
1993-05-13 |
1994-11-22 |
Yamanouchi Pharmaceut Co Ltd |
血小板活性化因子拮抗剤
|
|
JPH0714147A
(ja)
|
1993-06-25 |
1995-01-17 |
Dainippon Printing Co Ltd |
磁気記録媒体および磁気記録媒体の記録方法
|
|
JPH07145147A
(ja)
*
|
1993-11-26 |
1995-06-06 |
Yamanouchi Pharmaceut Co Ltd |
安息香酸誘導体又はその塩
|
|
WO1996012697A2
(en)
|
1994-10-21 |
1996-05-02 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active compounds
|
|
DE19529411A1
(de)
*
|
1995-08-10 |
1997-02-13 |
Bayer Ag |
Substituierte Tetrahydro-5-nitro-pyrimidine
|
|
JP3522930B2
(ja)
|
1995-12-06 |
2004-04-26 |
花王株式会社 |
抗菌剤及びこれを含有する口腔用組成物
|
|
EP0881220A4
(en)
|
1996-02-15 |
1999-04-21 |
Mitsubishi Chem Corp |
DIARYLSULTAME DERIVATIVES
|
|
KR19990087814A
(ko)
|
1996-04-24 |
1999-12-27 |
다케다 야쿠힌 고교 가부시키가이샤 |
과지방혈증 방지제로서의 융합 이미다조피리딘유도체
|
|
US6218506B1
(en)
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
|
US6518315B1
(en)
|
1997-10-21 |
2003-02-11 |
The University Of Sydney |
Medicinal uses of phenylaikanols and derivatives
|
|
CO4980891A1
(es)
|
1997-11-14 |
2000-11-27 |
Sanofi Sa |
Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
|
|
CO5011072A1
(es)
|
1997-12-05 |
2001-02-28 |
Lilly Co Eli |
Etanolaminas pirazinil substituidas como agfonistas de los receptores
|
|
TWI244481B
(en)
|
1998-12-23 |
2005-12-01 |
Pfizer |
3-azabicyclo[3.1.0]hexane derivatives useful in therapy
|
|
IL138686A0
(en)
|
1999-10-01 |
2001-10-31 |
Pfizer Prod Inc |
α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
|
|
WO2001030335A2
(en)
|
1999-10-22 |
2001-05-03 |
The Board Of Trustees Of The University Of Illinois |
Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
|
|
DE10027151A1
(de)
|
2000-05-31 |
2001-12-06 |
Bayer Ag |
Herbizide Mittel auf Basis von substituierten Carbonsäureamiden
|
|
JP4188078B2
(ja)
|
2000-06-28 |
2008-11-26 |
スミスクライン ビーチャム ピー エル シー |
湿式粉砕法
|
|
JP4329290B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
脂肪族含窒素五員環化合物
|
|
IL157766A0
(en)
|
2001-03-05 |
2004-03-28 |
Yissum Res Dev Co |
Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
|
|
JP4312402B2
(ja)
|
2001-07-31 |
2009-08-12 |
有限会社大長企画 |
抗うつ剤、抗更年期障害剤、抗老人性痴呆症剤、抗アルツハイマー剤
|
|
AU2002332659A1
(en)
|
2001-08-21 |
2003-03-03 |
Sepracor, Inc. |
2-substituted piperidines that are ligands for monoamine receptors and transporters
|
|
US6991814B2
(en)
|
2001-12-13 |
2006-01-31 |
Council Of Scientific And Industrial Research |
Herbal medicaments for the treatment of neurocerebrovascular disorders
|
|
JP4695839B2
(ja)
|
2001-12-14 |
2011-06-08 |
カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ |
神経脳血管障害を治療するための組成物
|
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP2004002517A
(ja)
|
2002-05-31 |
2004-01-08 |
Dae Sil Kim |
生姜成分を含む石鹸の組成物及びその製造方法
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
DE10320560A1
(de)
|
2003-05-07 |
2004-01-29 |
Brosig, Stefan, Dr. |
Mittel zur Bekämpfung der Alzheimer Erkrankung und/oder der Parkinson Krankheit
|
|
WO2004110389A2
(en)
|
2003-06-12 |
2004-12-23 |
Agy Therapeutics, Inc. |
Sigma ligands for neuronal regeneration and functional recovery
|
|
US7829562B2
(en)
|
2003-06-12 |
2010-11-09 |
M's Science Corporation |
Sigma ligands for neuronal regeneration and functional recovery
|
|
JP2007502828A
(ja)
|
2003-08-21 |
2007-02-15 |
ファイザー・プロダクツ・インク |
神経変性性疾患の治療のための化合物
|
|
BRPI0418634A
(pt)
|
2004-03-12 |
2007-05-29 |
Egis Gyogyszergyar Nyrt |
composição farmacêutica combinada para a inibição do declìnio das funções cognitivas
|
|
EP1752144A4
(en)
|
2004-05-31 |
2007-07-11 |
Kaneka Corp |
AGENT FOR PREVENTING / IMPROVING LIFESTYLE DISEASES CONTAINING AN ESSENTIAL CURCUMA OIL COMPONENT
|
|
CA2571614C
(en)
|
2004-06-21 |
2016-12-06 |
Proteome Sciences Plc |
Screening methods
|
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
US20080153917A1
(en)
|
2004-09-10 |
2008-06-26 |
Ucb Pharma, S.A. |
Sigma Receptor Ligands
|
|
US20080044356A1
(en)
|
2004-10-22 |
2008-02-21 |
Regents Of The University Of Minnesota |
Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof
|
|
WO2006066118A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment
|
|
ATE458754T1
(de)
|
2005-03-05 |
2010-03-15 |
Abbott Gmbh & Co Kg |
Screening-verfahren, verfahren zur aufreinigung nichtdiffundierbarer a-beta-oligomere, selektive antikörper gegen diese nichtdiffundierbaren a- beta-oligomere und verfahren zur herstellung dieser antikörper
|
|
KR20080041624A
(ko)
|
2005-06-15 |
2008-05-13 |
대릭 에스. 에치. 엘. 김 |
베타-아밀로이드 단백질-유발 안질환의 치료 방법
|
|
TW200726774A
(en)
|
2005-06-30 |
2007-07-16 |
Merck & Co Inc |
Composition and method for producing stable amyloid beta oligomers
|
|
US20070021413A1
(en)
|
2005-07-20 |
2007-01-25 |
Peter Herold |
Diamino alcohols as therapeutic compounds
|
|
ITRM20060007A1
(it)
|
2006-01-05 |
2007-07-06 |
Univ Bari |
Recettore sigma-2 metodo di screening di ligandi specifici e uso degli stessi in metodi diagnostici o terapeutici
|
|
US20070218491A1
(en)
|
2006-02-08 |
2007-09-20 |
Oligomerix, Inc. |
Oligomerization of amyloid proteins
|
|
WO2007109210A2
(en)
|
2006-03-17 |
2007-09-27 |
Herbalscience Singapore Pte. Ltd. |
Extracts and methods comprising curcuma species
|
|
US20100029654A1
(en)
|
2006-03-23 |
2010-02-04 |
Mount Sinai School Of Medicine |
Cardiovascular compositions and use of the same for the treatment of alzheimer's disease
|
|
WO2007126473A2
(en)
|
2006-04-10 |
2007-11-08 |
Oligomerix, Inc. |
Oligomerization of amyloid proteins
|
|
EP2035448A4
(en)
|
2006-06-01 |
2010-11-03 |
Elan Pharm Inc |
NEUROACTIVE FRAGMENTS OF APP
|
|
US7561775B2
(en)
|
2006-08-22 |
2009-07-14 |
Senko Advanced Components, Inc. |
Fiber optic protective shutter
|
|
CA2662723A1
(en)
|
2006-09-08 |
2008-03-13 |
Vib Vzw |
Means and methods for the production of amyloid oligomers
|
|
WO2008042755A2
(en)
|
2006-09-29 |
2008-04-10 |
Cognition Therapeutics, Inc. |
Inhibitors of cognitive decline
|
|
US20080131233A1
(en)
|
2006-10-17 |
2008-06-05 |
Yao Chun I |
Plate-shaped fastener device
|
|
US20100028333A1
(en)
|
2006-12-15 |
2010-02-04 |
Getty Krista L |
Receptor for amyloid beta and uses thereof
|
|
WO2008134034A1
(en)
|
2007-04-26 |
2008-11-06 |
Yale University |
Prion protein as a receptor for amyloid-beta oligomers
|
|
AU2008254905A1
(en)
|
2007-05-15 |
2008-11-27 |
Helicon Therapeutics, Inc. |
Methods of treating cognitive disorders by inhibition of Gpr12
|
|
CN101121670A
(zh)
|
2007-09-11 |
2008-02-13 |
上海紫源制药有限公司 |
一种3,4-二甲氧基-N-[3-(4-甲氧基苯基)-1-甲基-正丙基]-β-苯乙胺盐酸盐的制备方法
|
|
WO2009048631A1
(en)
|
2007-10-11 |
2009-04-16 |
University Of Tennessee Research Foundation |
PREPARATION OF PURIFIED COVALENTYLY CROSS-LINKED A β OLIGOMERS AND USES THEREOF
|
|
US8304547B2
(en)
|
2007-10-24 |
2012-11-06 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
|
WO2009059214A1
(en)
|
2007-11-02 |
2009-05-07 |
The Regents Of The University Of California |
Abeta-binding small molecules
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
US20110092445A1
(en)
|
2008-07-25 |
2011-04-21 |
Abbott Laboratories |
Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
|
|
KR101515822B1
(ko)
|
2008-11-29 |
2015-04-29 |
더 타일랜드 리서치 펀드 |
바이러스와 타겟 세포의 상호작용 저해
|
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
|
PE20120578A1
(es)
|
2009-02-10 |
2012-06-17 |
Abbott Lab |
Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos
|
|
ES2638779T3
(es)
|
2009-03-16 |
2017-10-24 |
Pangu Biopharma Limited |
Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
|
|
BRPI1007624A2
(pt)
|
2009-04-09 |
2016-07-26 |
Cognition Therapeutics Inc |
composto, método para preparar uma composição, composto ou sal farmaceuticamente aceitável deste e uso de um composto ou um sal farmaceuticamente aceitável deste
|
|
ES2581178T3
(es)
|
2009-07-29 |
2016-09-01 |
Pharnext |
Nuevas herramientas de diagnóstico para enfermedad de Alzheimer
|
|
CN102595884B
(zh)
|
2009-07-31 |
2014-12-03 |
考格尼申治疗股份有限公司 |
认知衰退的抑制剂
|
|
US20150160228A1
(en)
|
2010-02-05 |
2015-06-11 |
Susan Catalano |
Compositions and method for determining the efficacy of amyloidosis treatments
|
|
US20130071330A1
(en)
|
2010-02-26 |
2013-03-21 |
Susan Catalano |
Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
|
|
WO2012027548A1
(en)
|
2010-08-25 |
2012-03-01 |
The Feinstein Institute For Medical Research |
Compounds and methods for prevention and treatment of alzheimer's and other diseases
|
|
AU2012212219B2
(en)
|
2011-02-02 |
2017-03-23 |
Cognition Therapeutics, Inc. |
Isolated compounds from turmeric oil and methods of use
|
|
EP2747759A4
(en)
*
|
2011-08-25 |
2015-05-13 |
Cognition Therapeutics Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
JP2014529613A
(ja)
|
2011-08-25 |
2014-11-13 |
コグニションセラピューティクス，インコーポレイテッド |
神経変性疾患を治療する組成物及び方法
|
|
WO2015020523A1
(en)
|
2013-08-07 |
2015-02-12 |
Stichting Vu-Vumc |
Biomarkers for early diagnosis of alzheimer's disease
|
|
DK3498692T3
(da)
|
2014-01-31 |
2022-05-16 |
Cognition Therapeutics Inc |
Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration
|
|
BR112019023851A2
(pt)
*
|
2017-05-15 |
2020-08-18 |
Cognition Therapeutics, Inc. |
compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
|
|
WO2019089988A1
(en)
|
2017-11-01 |
2019-05-09 |
Cognition Therapeutics, Inc. |
Isoindoline compositions and methods for treating neurodegenerative disease
|
|
CN110283082A
(zh)
|
2019-07-15 |
2019-09-27 |
泰州职业技术学院 |
一种3-苯基丙胺的制备方法
|
|
IL303592A
(en)
|
2020-12-11 |
2023-08-01 |
Cognition Therapeutics Inc |
Compositions for treating dry age-related macular degeneration (amd)
|